Bacteroides vesicles promote functional alterations in the gut microbiota composition

被引:3
|
作者
Shagaleeva, Olga Yu. [1 ]
Kashatnikova, Daria A. [1 ,2 ]
Kardonsky, Dmitry A. [1 ]
Efimov, Boris A. [1 ,3 ]
Ivanov, Viktor A. [1 ]
Smirnova, Svetlana V. [2 ]
Evsiev, Suleiman S. [1 ]
Zubkov, Eugene A. [4 ]
Abramova, Olga V. [4 ]
Zorkina, Yana A. [4 ]
Morozova, Anna Y. [4 ]
Vorobeva, Elizaveta A. [1 ]
Silantiev, Artemiy S. [1 ]
Kolesnikova, Irina V. [1 ]
Markelova, Maria I. [5 ]
Olekhnovich, Evgenii I. [1 ]
Morozov, Maxim D. [1 ]
Zoruk, Polina Y. [1 ]
Boldyreva, Daria I. [1 ]
Kazakova, Victoriia D. [1 ]
Vanyushkina, Anna A. [6 ]
Chaplin, Andrei V. [1 ,3 ]
Grigoryeva, Tatiana V. [5 ]
Zakharzhevskaya, Natalya B. [1 ]
机构
[1] Phys Chem Med Fed Med Biol Agcy, Lopukhin Fed Res & Clin Ctr, Moscow, Russia
[2] Russian Acad Sci, Vavilov Inst Gen Genet, Lab Ecol Genet, Moscow, Russia
[3] Pirogov Russian Natl Res Med Univ, Dept Microbiol & Virol, Moscow, Russia
[4] VP Serbsky Natl Med Res Ctr Psychiat & Narcol, Dept Basic & Appl Neurobiol, Moscow, Russia
[5] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia
[6] Skolkovo Inst Sci & Technol, Vladimir Zelman Ctr Neurobiol & Brain Rehabil, Moscow, Russia
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 11期
基金
俄罗斯科学基金会;
关键词
HS-GC/MS; IBD; OMVs; DSS-induced colitis; MURINE MODEL; COLITIS; DISEASE; MANAGEMENT;
D O I
10.1128/spectrum.00636-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Inflammatory bowel diseases are characterized by chronic intestinal inflammation and alterations in the gut microbiota composition. Bacteroides fragilis, which secretes outer membrane vesicles (OMVs) with polysaccharide A (PSA), can moderate the inflammatory response and possibly alter the microbiota composition. In this study, we created a murine model of chronic sodium dextran sulfate (DSS)-induced intestinal colitis and treated it with B. fragilis OMVs. We monitored the efficiency of OMV therapy by determining the disease activity index (DAI) and performing histological examination (HE) of the intestine before and after vesicle exposure. We also analyzed the microbiota composition using 16S rRNA gene sequencing. Finally, we evaluated the volatile compound composition in the animals' stools by HS-GC/MS to assess the functional activity of the microbiota. We observed more effective intestinal repair after OMV treatment according to the DAI and HE. A metabolomic study also revealed changes in the functional activity of the microbiota, with a predominance of phenol and pentanoic acid in the control group compared to the group treated with DSS and the group treated with OMVs (DSS OMVs). We also observed a positive correlation of these metabolites with Saccharibacteria and Acetivibrio in the control group, whereas in the DSS group, there was a negative correlation of phenol and pentanoic acid with Lactococcus and Romboutsia. According to the metabolome and sequencing data, the microbiota composition of the DSS-treated OMV group was intermediate between that of the control and DSS groups. OMVs not only have an anti-inflammatory effect but also contribute to the recovery of the microbiota composition.IMPORTANCEBacteroides fragilis vesicles contain superficially localized polysaccharide A (PSA), which has unique immune-modulating properties. Isolated PSA can prevent chemically induced colitis in a murine model. Outer membrane vesicles (OMVs) also contain digestive enzymes and volatile metabolites that can complement the anti-inflammatory properties of PSA. OMVs showed high therapeutic activity against sodium dextran sulfate-induced colitis, as confirmed by histological assays. 16S rRNA sequencing of fecal samples from different inflammatory stages, supplemented with comprehensive metabolome analysis of volatile compounds conducted by HS-GC/MS, revealed structural and functional alterations in the microbiota composition under the influence of OMVs. Correlation analysis of the OMV-treated and untreated experimental animal groups revealed associations of phenol and pentanoic acid with Lactococcus, Romboutsia, Saccharibacteria, and Acetivibrio. Bacteroides fragilis vesicles contain superficially localized polysaccharide A (PSA), which has unique immune-modulating properties. Isolated PSA can prevent chemically induced colitis in a murine model. Outer membrane vesicles (OMVs) also contain digestive enzymes and volatile metabolites that can complement the anti-inflammatory properties of PSA. OMVs showed high therapeutic activity against sodium dextran sulfate-induced colitis, as confirmed by histological assays. 16S rRNA sequencing of fecal samples from different inflammatory stages, supplemented with comprehensive metabolome analysis of volatile compounds conducted by HS-GC/MS, revealed structural and functional alterations in the microbiota composition under the influence of OMVs. Correlation analysis of the OMV-treated and untreated experimental animal groups revealed associations of phenol and pentanoic acid with Lactococcus, Romboutsia, Saccharibacteria, and Acetivibrio.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Alterations of the Composition and Neurometabolic Profile of Human Gut Microbiota in Major Depressive Disorder
    Kovtun, Alexey S.
    Averina, Olga, V
    Angelova, Irina Y.
    Yunes, Roman A.
    Zorkina, Yana A.
    Morozova, Anna Y.
    Pavlichenko, Alexey, V
    Syunyakov, Timur S.
    Karpenko, Olga A.
    Kostyuk, George P.
    Danilenko, Valery N.
    BIOMEDICINES, 2022, 10 (09)
  • [22] Gut microbiota composition alterations are associated with the onset of diabetes in kidney transplant recipients
    Lecronier, Marie
    Tashk, Parvine
    Tamzali, Yanis
    Tenaillon, Olivier
    Denamur, Erick
    Barrou, Benoit
    Aron-Wisnewsky, Judith
    Tourret, Jerome
    PLOS ONE, 2020, 15 (01):
  • [23] Alterations in Gut Glutamate Metabolism Associated with Changes in Gut Microbiota Composition in Children with Autism Spectrum Disorder
    Wang, Mingbang
    Wan, Jing
    Rong, Han
    He, Fusheng
    Wang, Hui
    Zhou, Jiaxiu
    Cai, Chunquan
    Wang, Yan
    Xu, Ruihuan
    Yin, Zhaoqing
    Zhou, Wenhao
    MSYSTEMS, 2019, 4 (01)
  • [24] Modulation of the gut microbiota to promote health
    Peterson, Scott
    Freeze, Hudson
    Sharma, Vandana
    JOURNAL OF NEUROVIROLOGY, 2015, 21 : S55 - S55
  • [25] Alterations in the taxanomic and predicted functional profile of gut microbiota in Behcet's Disease
    Low, Liying
    Suleiman, Kusy
    Murad, Mariam
    Shamdas, Mohith
    Mitton, Debbie
    Situnayake, Deva
    Murray, Philip Ian
    Wallace, Graham R.
    Rauz, Saaeha
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [26] ALTERATIONS OF GUT MICROBIOTA IN FUNCTIONAL DIARRHEA - A RETROSPECTIVE SINGLE-CENTER STUDY
    Pugliano, C. L.
    Di Pierro, F.
    Gerardi, V
    Piccirelli, S.
    Salvi, D.
    Spada, C.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S142 - S142
  • [27] Gut Microbiota Alterations and Their Functional Differences in Depression According to Enterotypes in Asian Individuals
    Park, Sunmin
    Li, Chen
    Wu, Xuangao
    Zhang, Tianshun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [28] Alterations in the taxanomic and predicted functional profile of gut microbiota in Behcet's disease
    Low, L.
    Murad, M.
    Debbie, D.
    Situnayake, D.
    Murray, P. I.
    Rauz, S.
    Wallace, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S163 - S163
  • [29] Dietary Nucleotides Promote Neonatal Rat Microbiota-Gut-Brain Axis Development by Affecting Gut Microbiota Composition and Metabolic Function
    Qu, Zhihao
    Tian, Peijun
    Wang, Linlin
    Jin, Xing
    Guo, Min
    Lu, Jingyu
    Zhao, Jianxin
    Chen, Wei
    Wang, Gang
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (49) : 19622 - 19637
  • [30] Alterations of the gut microbiota in patients with schizophrenia
    Li, Zhuocan
    Tao, Xiangkun
    Wang, Dongfang
    Pu, Juncai
    Liu, Yiyun
    Gui, Siwen
    Zhong, Xiaogang
    Yang, Dan
    Zhou, Haipeng
    Tao, Wei
    Chen, Weiyi
    Chen, Xiaopeng
    Chen, Yue
    Chen, Xiang
    Xie, Peng
    FRONTIERS IN PSYCHIATRY, 2024, 15